Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome

Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by a clonal expansion of megakaryocytes. ET can result in both arterial and venous thrombosis. Involvement of the coronary arteries has been reported. Patients who harbor a CALR mutation are half as likely to suffer a thro...

Full description

Saved in:
Bibliographic Details
Main Authors: Bassel Nazha, Gwenalyn Garcia, Ruben Kandov, Marcel Odaimi
Format: Article
Language:English
Published: Wiley 2015-01-01
Series:Case Reports in Hematology
Online Access:http://dx.doi.org/10.1155/2015/161764
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850175960819695616
author Bassel Nazha
Gwenalyn Garcia
Ruben Kandov
Marcel Odaimi
author_facet Bassel Nazha
Gwenalyn Garcia
Ruben Kandov
Marcel Odaimi
author_sort Bassel Nazha
collection DOAJ
description Essential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by a clonal expansion of megakaryocytes. ET can result in both arterial and venous thrombosis. Involvement of the coronary arteries has been reported. Patients who harbor a CALR mutation are half as likely to suffer a thrombotic event as compared to patients with a JAK2 mutation. We report a case of CALR-mutated ET whose initial disease manifestation was a non-ST segment elevation myocardial infarction.
format Article
id doaj-art-ba7fe5d6c61d4c078af424763b31fd4c
institution OA Journals
issn 2090-6560
2090-6579
language English
publishDate 2015-01-01
publisher Wiley
record_format Article
series Case Reports in Hematology
spelling doaj-art-ba7fe5d6c61d4c078af424763b31fd4c2025-08-20T02:19:21ZengWileyCase Reports in Hematology2090-65602090-65792015-01-01201510.1155/2015/161764161764Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary SyndromeBassel Nazha0Gwenalyn Garcia1Ruben Kandov2Marcel Odaimi3Department of Medicine, Staten Island University Hospital, Staten Island, NY 10305, USADepartment of Hematology/Oncology, Staten Island University Hospital, Staten Island, NY 10305, USADepartment of Cardiology, Staten Island University Hospital, Staten Island, NY 10305, USADepartment of Hematology/Oncology, Staten Island University Hospital, Staten Island, NY 10305, USAEssential thrombocythemia (ET) is a myeloproliferative neoplasm characterized by a clonal expansion of megakaryocytes. ET can result in both arterial and venous thrombosis. Involvement of the coronary arteries has been reported. Patients who harbor a CALR mutation are half as likely to suffer a thrombotic event as compared to patients with a JAK2 mutation. We report a case of CALR-mutated ET whose initial disease manifestation was a non-ST segment elevation myocardial infarction.http://dx.doi.org/10.1155/2015/161764
spellingShingle Bassel Nazha
Gwenalyn Garcia
Ruben Kandov
Marcel Odaimi
Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
Case Reports in Hematology
title Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
title_full Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
title_fullStr Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
title_full_unstemmed Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
title_short Calreticulin Mutated Essential Thrombocythemia Presenting as Acute Coronary Syndrome
title_sort calreticulin mutated essential thrombocythemia presenting as acute coronary syndrome
url http://dx.doi.org/10.1155/2015/161764
work_keys_str_mv AT basselnazha calreticulinmutatedessentialthrombocythemiapresentingasacutecoronarysyndrome
AT gwenalyngarcia calreticulinmutatedessentialthrombocythemiapresentingasacutecoronarysyndrome
AT rubenkandov calreticulinmutatedessentialthrombocythemiapresentingasacutecoronarysyndrome
AT marcelodaimi calreticulinmutatedessentialthrombocythemiapresentingasacutecoronarysyndrome